Decibel Therapeutics, Inc.

NasdaqGS:DBTX Stock Report

Market Cap: US$124.3m

Decibel Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DBTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders00%
Private Companies2,8670.0113%
Public Companies2,097,3148.28%
General Public6,647,94126.2%
Institutions6,856,45427.1%
VC/PE Firms9,721,13538.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.5%
OrbiMed Advisors LLC
4,945,192US$24.3m0%0.41%
12.4%
Third Rock Ventures, LLC
3,139,685US$15.4m0%5.68%
8.28%
Regeneron Pharmaceuticals, Inc.
2,097,314US$10.3m0%no data
7.15%
BlackRock, Inc.
1,811,483US$8.9m0.3%no data
6.46%
GV Management Company, LLC
1,636,258US$8.0m0%0.82%
4.61%
SR One Capital Management, LP
1,168,663US$5.7m0%2.45%
3.17%
Samsara BioCapital LLC
801,629US$3.9m0%1.51%
2.54%
The Vanguard Group, Inc.
642,325US$3.2m0%no data
1.95%
Bessemer Investment Management LLC
494,071US$2.4m0%no data
1.29%
Harvard Management Company, Inc.
326,029US$1.6m-0.84%0.16%
0.79%
Newtyn Management, LLC
200,000US$982.0k-21.2%0.2%
0.79%
UBS O'Connor LLC
199,200US$978.1k5.18%0.04%
0.63%
Millennium Management LLC
159,224US$781.8k-35.4%no data
0.61%
Bronte Capital Management Pty Ltd
154,878US$760.4k-1.64%0.05%
0.52%
Point72 Asset Management, L.P.
132,010US$648.2k-0.42%no data
0.47%
Bridgeway Capital Management, LLC
119,100US$584.8k0%0.01%
0.46%
Geode Capital Management, LLC
115,567US$567.4k0%no data
0.41%
JP Morgan Asset Management
103,327US$507.3k-6.57%no data
0.23%
Neuberger Berman Investment Advisers LLC
58,800US$288.7k275%no data
0.17%
Acuitas Investments, LLC
41,960US$206.0k0%0.09%
0.16%
State Street Global Advisors, Inc.
40,960US$201.1k0%no data
0.16%
BNY Mellon Asset Management
40,489US$198.8k0%no data
0.14%
Dimensional Fund Advisors LP
34,607US$169.9k0%no data
0.14%
Renaissance Technologies LLC
34,400US$168.9k5.85%no data
0.099%
Atlas Capital Advisors Inc.
25,000US$122.7k0%0.02%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/06 00:34
End of Day Share Price 2023/09/22 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Decibel Therapeutics, Inc. is covered by 8 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Huidong WangBarclays
Matthew LuchiniBMO Capital Markets Equity Research